APP, amyloid beta precursor protein, 351

N. diseases: 485; N. variants: 114
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0002395
Disease:
Alzheimer's Disease
0.060 GeneticVariation BEFREE We now report that miR-342-5p is upregulated in APP/PS1, PS1ΔE9, and PS1-M146V transgenic AD mice, and that this upregulation is mechanistically linked to elevated β-catenin, c-Myc, and interferon regulatory factor-9. 24440716 2014
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0002395
Disease:
Alzheimer's Disease
0.060 GeneticVariation BEFREE A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with disease status in two independent families and doubled risk for Alzheimer's disease in seven independent case-control series with a total of more than 11,000 cases and controls of European descent. 24336208 2014
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0338656
Disease:
Impaired cognition
0.010 GeneticVariation BEFREE Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V). 15578094 2004
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0338451
Disease:
Frontotemporal dementia
0.010 GeneticVariation BEFREE The PS-1 M146V mutation was found in the 50-year-old subject (the proband) with family history of early-onset FTD. 23489366 2013
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0276496
Disease:
Familial Alzheimer Disease (FAD)
0.010 GeneticVariation BEFREE To investigate the factors that drive the Abeta42/Abeta40 ratio and amyloid pathogenesis and to investigate the possible interactions between wild-type and FAD mutant PS1, which are co-expressed in transgenic animals, we expressed the PS1 M146V knock-in allele either on wild-type PS1 (PS1M146V/+) or PS1 null (PS1M146V/-) background and crossed these alleles with the Tg2576 APP transgenic mice. 16574645 2006
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0009241
Disease:
Cognition Disorders
0.010 GeneticVariation BEFREE Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V). 15578094 2004
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0751071
Disease:
Familial Dementia
0.010 GeneticVariation BEFREE Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation. 23489366 2013
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0750901
Disease:
Alzheimer Disease, Early Onset
0.010 GeneticVariation BEFREE Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. 27120160 2016
dbSNP: rs1223904774
rs1223904774
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0494463
Disease:
Alzheimer Disease, Late Onset
0.010 GeneticVariation BEFREE The link between Val232Met variant of phospholipase D3 (PLD3) and late-onset Alzheimer's disease (AD) is still obscure. 31121321 2019
dbSNP: rs1224230940
rs1224230940
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0002395
Disease:
Alzheimer's Disease
0.010 GeneticVariation BEFREE Five point mutations within the amyloid beta-protein (Abeta) sequence of the APP gene are associated with hereditary diseases which are similar or identical to Alzheimer's disease and encode: the A21G (Flemish), E22G (Arctic), E22K (Italian), E22Q (Dutch) and the D23N (Iowa) amino acid substitutions. 18602473 2008
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0276496
Disease:
Familial Alzheimer Disease (FAD)
0.050 GeneticVariation BEFREE These in vitro results were confirmed by in vivo experiments in transgenic mice expressing the PS2 N141I FAD mutant. 17962197 2008
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0276496
Disease:
Familial Alzheimer Disease (FAD)
0.050 GeneticVariation BEFREE These results strongly suggest that the PS2 mutation (N141I) linked to FAD alters the metabolism of A beta/betaAPP to foster the production of the form of A beta that most readily deposits in amyloid plaques. 9050898 1997
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0276496
Disease:
Familial Alzheimer Disease (FAD)
0.050 GeneticVariation BEFREE Functional analysis of such cleavage defective PS2 carrying the FAD mutation Asn-141 --> Ile showed that its Abeta42 producing activity was strongly reduced compared with cleavage-competent FAD PS2. 10575009 1999
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0276496
Disease:
Familial Alzheimer Disease (FAD)
0.050 GeneticVariation BEFREE A novel factor, termed Humanin (HN), antagonizes against neurotoxicity by various types of familial Alzheimer's disease (AD) genes [V642I and K595N/M596L (NL) mutants of amyloid precursor protein (APP), M146L-presenilin (PS) 1, and N141I-PS2] and by Abeta1-43 with clear action specificity ineffective on neurotoxicity by polyglutamine repeat Q79 or superoxide dismutase 1 mutants. 11717357 2001
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0276496
Disease:
Familial Alzheimer Disease (FAD)
0.050 GeneticVariation BEFREE The present study investigated the influence of two familial Alzheimer's-disease-linked presenilin2 variants (N141I and M239V) and a loss-of-function presenilin2 mutant (D263A) on the activity of the transient receptor potential canonical (TRPC)6 Ca(2+) entry channel. 15601622 2005
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0011265
Disease:
Presenile dementia
0.010 GeneticVariation BEFREE We herein report the case of a German EOAD patient with a family history of dementia and a missense mutation at codon 141 (N141I) </span>of the PSEN2 gene. 19073399 2008
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C4086165
Disease:
Childhood Neuroblastoma
0.010 GeneticVariation BEFREE COS-1 cells doubly transfected with cDNAs for N141I mutant PS2 and human beta-amyloid precursor protein (betaAPP) or a C-terminal fragment thereof, as well as mouse Neuro2a neuroblastoma cells stably transfected with N141I mutant PS2 alone, secreted 1.5- to 10-fold more A beta ending at residues 42 (or 43) [A beta42(43)] compared with those expressing the wild-type PS2. 9050898 1997
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0700095
Disease:
Central neuroblastoma
0.010 GeneticVariation BEFREE COS-1 cells doubly transfected with cDNAs for N141I mutant PS2 and human beta-amyloid precursor protein (betaAPP) or a C-terminal fragment thereof, as well as mouse Neuro2a neuroblastoma cells stably transfected with N141I mutant PS2 alone, secreted 1.5- to 10-fold more A beta ending at residues 42 (or 43) [A beta42(43)] compared with those expressing the wild-type PS2. 9050898 1997
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0750901
Disease:
Alzheimer Disease, Early Onset
0.010 GeneticVariation BEFREE We herein report the case of a German EOAD patient with a family history of dementia and a missense mutation at codon 141 (N141I) of the PSEN2 gene. 19073399 2008
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0497327
Disease:
Dementia
0.010 GeneticVariation BEFREE We herein report the case of a German EOAD patient with a family history of dementia and a missense mutation at codon 141 (N141I) </span>of the PSEN2 gene. 19073399 2008
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0424295
Disease:
Hyperactive behavior
0.010 GeneticVariation BEFREE Although hyperactivity and hypersynchronicity were respectively detected in mice expressing the PS2-N141I or the APP Swedish mutant alone, the increase in cross-frequency coupling specifically characterized the 6-month-old PS2APP mice, just before the surge of the cognitive decline. 27889678 2017
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0234985
Disease:
Mental deterioration
0.010 GeneticVariation BEFREE Although hyperactivity and hypersynchronicity were respectively detected in mice expressing the PS2-N141I or the APP Swedish mutant alone, the increase in cross-frequency coupling specifically characterized the 6-month-old PS2APP mice, just before the surge of the cognitive decline. 27889678 2017
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0338656
Disease:
Impaired cognition
0.010 GeneticVariation BEFREE Although hyperactivity and hypersynchronicity were respectively detected in mice expressing the PS2-N141I or the APP Swedish mutant alone, the increase in cross-frequency coupling specifically characterized the 6-month-old PS2APP mice, just before the surge of the cognitive decline. 27889678 2017
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0338445
Disease:
Familial Alzheimer's disease of early onset
0.010 GeneticVariation BEFREE To gain insights into the significance of presenilins (PS) in the pathogenetic mechanisms of early-onset familial Alzheimer disease (FAD), we expressed cDNAs for wild-type PS2 and PS2 with the Volga German (N141I) mutation in cultured cells and then examined the metabolism of the transfected proteins and their effect on the C-terminal properties of secreted amyloid beta protein (A beta). 9050898 1997
dbSNP: rs1231783932
rs1231783932
Entrez Id: 351
Gene Symbol: APP
APP
CUI: C0027819
Disease:
Neuroblastoma
0.010 GeneticVariation BEFREE COS-1 cells doubly transfected with cDNAs for N141I mutant PS2 and human beta-amyloid precursor protein (betaAPP) or a C-terminal fragment thereof, as well as mouse Neuro2a neuroblastoma cells stably transfected with N141I mutant PS2 alone, secreted 1.5- to 10-fold more A beta ending at residues 42 (or 43) [A beta42(43)] compared with those expressing the wild-type PS2. 9050898 1997